Trial Search Results

aTBS for Treatment of Depression in AUD

This study evaluates an accelerated schedule of theta-burst stimulation using a transcranial magnetic stimulation device for improvement of depressive symptoms and drinking behavior in individuals with alcohol dependence. In this open label study, all participants will receive accelerated theta-burst stimulation.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Device: Accelerated theta burst treatment




1. Participant aged 18-65 years old with diagnosis of alcohol use disorder.

   2. Participant may also choose to or not to take pharmacotherapy during the study period.

   3. Participant has tried at least one medication in the past that has not helped the
   alcohol use disorder. If participants are taking medication, they must be on stable
   psychotropic medication or psychotherapy for at least 6 weeks prior to the study with
   plans to continue throughout study enrollment.

   4. Participant needs to be at least one week after last alcohol/ substance use and had
   the last drink within one year of the beginning of the study participation.

   5. Participant endorses depressive symptom(s), indicated by a MARDS score >= 20.

   6. All participants must be assigned to a psychiatrist and agree to continue to be
   assigned to a psychiatrist throughout study enrollment.

   7. Able to read, understand, and provide written, dated informed consent prior to
   screening. Participants will be deemed likely to comply with study protocol and
   communicate with study personnel about adverse events and other clinically important

Ages Eligible for Study

18 Years - 65 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Romina Nejad, MSc
Not Recruiting